The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides

Purinergic Signalling

Volumn 3, Issue 1-2, 2007, Pages 91-97

  Vylkova, Slavena ^a   Sun, Jianing N ^a   Edgerton, Mira ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

ATP release; Candida albicans; Cationic antimicrobial peptides; Defensins; Histatin

Indexed keywords

EID: 33947672319     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-006-9040-0     Document Type: Article

References (59)

1. Brown KL, Hancock RE (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24-30
2. Lin AL, Johnson DA, Patterson TF et al (2001) Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol 16:270-278
3. McPhee JB, Hancock RE (2005) Function and therapeutic potential of host defence peptides. J Pept Sci 11:677-687
4. Koczulla AR, Bals R (2003) Antimicrobial peptides: Current status and therapeutic potential. Drugs 63:389-406
5. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55
6. Lehrer RI, Ganz T (1996) Endogenous vertebrate antibiotics. Defensins, protegrins and other cysteine-rich antimicrobial peptides. Ann N Y Acad Sci 797:228-239
7. Kagan BL, Ganz T, Lehrer RI (1994) Defensins: A family of antimicrobial and cytotoxic peptides. Toxicology 87:131-149
8. Matsuzaki K (1998) Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391-400
9. Koo SP, Bayer AS, Yeaman MR (2001) Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides. Infect Immun 69:4916-4922
10. Lehrer RI, Barton A, Daher KA et al (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 84:553-561
11. Chapple DS, Hussain R, Joannou CL et al (2004) Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob Agents Chemother 48:2190-2198
12. Blumenthal KM, Seibert AL (2003) Voltage-gated sodium channel toxins: poisons, probes, and future promise. Cell Biochem Biophys 38:215-238
13. Williams K (1997) Interactions of polyamines with ion channels. Biochem J 325:289-297
14. Jouirou B, Mouhat S, Andreotti N et al (2004) Toxin determinants required for interaction with voltage-gated K+ channels. Toxicon 43:909-914
15. Mathie A, Wooltorton JR, Watkins CS (1998) Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 30:13-24
16. Edgerton M, Koshlukova SE, Lo TE et al (1998) Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 273:20438-20447
17. Li XS, Reddy MS, Baev D et al (2003) Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem 278:28553-28561
18. Ruissen AL, Groenink J, Helmerhorst EJ et al (2001) Effects of histatin 5 and derived peptides on Candida albicans. Biochem J 356:361-368
19. Veerman EC, Nazmi K, Van't Hof W et al (2004) Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J 381:447-452
20. Murakami Y, Shizukuishi S, Tsunemitsu A et al (1991) Binding of a histidine-rich peptide to Porphyromonas gingivalis. FEMS Microbiol Lett 66:253-256
21. Koshlukova SE, Araujo MW, Baev D et al (1999) Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem 274:18872-18879
22. Xu Y, Ambudkar I, Yamagashi H et al (1999) Histatin 3-mediated killing of Candida albicans: Effect of extracellular salt concentration on binding and internalization. Antimicrob Agents Chemother 43:2256-2262
23. Baev D, Li X, Edgerton M (2001) Genetically engineered human salivary histatin genes are functional in Candida albicans: Development of a new system for studying histatin candidacidal activity. Microbiology 147:3323-3334
24. Baev D, Li XS, Dong J et al (2002) Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans. Infect Immun 71:3251-3260
25. Baev D, Rivetta A, Li XS et al (2003) Killing of Candida albicans by human salivary histatin 5 is modulated, but not determined, by the potassium transporter TOK1. Infect Immun 71:3251-3260
26. Baev D, Rivetta A, Vylkova S et al (2004) The TRK1 potassium transporter is the critical effector target for killing of Candida albicans by the cationic protein, Histatin 5. J Biol Chem 279:55060-55072
27. Vylkova S, Li XS, Berner JC et al (2006) Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob Agents Chemother 50:324-331
28. Di Virgilio F (1995) The P2Z purinoreceptors: An intriguing role in immunity, inflammation and cell death. Immunol Today 16:524-528
29. Ferrari D, Pizzirani C, Adinolfi E et al (2004) The antibiotic polymyxin B modulates P2X7 receptor function. J Immunol 173:4652-4660
30. Lopes-Buesa P, Pfund C, Craig EA (1998) The biochemical properties of the ATPase activity of a 70-kDa heat shock protein (Hsp70) are governed by the C-terminal domains. Proc Natl Acad Sci U S A 95:15253-15258
31. Gyurko C, Lendenmann U, Troxler RF et al (2000) Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemother 44:348-354
32. Lupetti A, Paulusma-Annema A, Welling MM et al (2000) Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother 44:3257-3263
33. Viejo-Diaz M, Andres MT, Fierro JF (2004) Effects of human lactoferrin on the cytoplasmic membrane of Candida albicans cells related with its candidacidal activity. FEMS Immunol Med Microbiol 42:181-185
34. Viejo-Diaz M, Andres MT, Fierro JF (2004) Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob Agents Chemother 48:1242-1248
35. Ulvatne H, Haukland HH, Olsvik O et al (2001) Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett 492:62-65
36. van der Kraan MIA, van Marle J, Nazmi K et al (2005) Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides 26:1537-1542
37. Lupetti A, Paulusma-Annemma A, Senesi S et al (2002) Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin. Antimicrob Agents Chemother 46:1634-1639
38. Tanida T, Okamoto T, Ueta E et al (2006) Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells. J Antimicrob Chemother 57:94-103
39. Monk BC, Niimi K, Lin S et al (2005) Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that blocks azole resistance. Antimicrob Agents Chemother 49:57-70
40. Skerlavaj B, Romeo D, Gennaro R (1990) Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect Immun 58:3724-3730
41. Sadler K, Eom KD, Yang JL et al (2002) Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 41:14150-14157
42. Sahl HG, Pag U, Bonness S et al (2005) Mammalian defensins: Structures and mechanism of antibiotic activity. J Leukoc Biol 77:466-475
43. Kagan BL, Ganz T, Lehrer RI (1994) Defensins: A family of antimicrobial and cytotoxic peptides. Toxicology 87:131-149
44. Chen H, Xu Z, Peng L et al (2005) Recent advances in the research and development of human defensins. Peptides 27:931-940
45. Edgerton M, Koshlukova SE, Araujo MW et al (2000) Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 44:3310-3316
46. Vylkova S, Nayyar N, Li W et al (2007) Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob Agents Chemother 51:154-161
47. den Hertog AL, van Marle J, van Veen HA et al (2005) Candidacidal effects of two antimicrobial peptides: Histatin 5 causes small membrane defects, but LL37 causes massive disruption of the cell membrane. Biochem J 388:689-695
48. Ouhara K, Komatsuzawa H, Yamada S et al (2005) Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55:888-896
49. Peschel A, Otto M, Jack RW et al (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405-8410
50. Elssner A, Duncan M, Gavrilin M et al (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 172:4987-4994
51. Mangoni ML, Saugar JM, Dellisanti M et al (2005) Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem 280:984-990
52. Jouenne T, Mor A, Bonato H et al (1998) Antibacterial activity of synthetic dermaseptins against growing and non-growing Escherichia coli cultures. J Antimicrob Chemother 42:87-90
53. Soote PJ, Holyoak CD, Bracey D et al (1998) Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae. Antimicrob Agents Chemother 42:2160-2170
54. Abee T, Krockel L, Hill C (1995) Bacteriocins: Modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol 28:169-185
55. Bowdish DME, Davidson DJ, Scott MG et al (2005) Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49:1727-1732
56. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6:551-557
57. Oppenheim JJ, Yang D (2005) Alarmins: Chemotactic activators of immune responses. Curr Opin Immunol 17:359-365
58. 2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad Sci U S A 101:9479-9484
59. Granstein RD, Ding W, Huang J et al (2005) Augmentation of cutaneous immune responses by ATP gamma S: Purinergic agonists define a novel class of immunologic adjuvants. J Immunol 174:7725-7731